Here are the DEF 14A proxy statements from MetLife, Inc. (MET) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow MET and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MET filings page.
MetLife, Inc. is asking shareholders to vote at its virtual-only 2026 annual meeting on three items: electing 11 directors for one-year terms, ratifying Deloitte & Touche LLP as auditor for 2026, and approving on an advisory basis executive compensation.
The proxy highlights the second year of MetLife’s five-year New Frontier strategy, targeting double-digit adjusted EPS growth, 15–17% adjusted ROE, a 100 basis point reduction in the direct expense ratio from 12.3%, and more than $25 billion in free cash flow over 2025–2029. In 2025, net income available to common shareholders was $3,173 million or $4.71 per diluted share, compared with $4,226 million or $5.94 in 2024, while ROE was 12.9% versus 16.9%.
The filing describes strong pay‑for‑performance alignment, with most 2025 total compensation for named executive officers variable and 70% of stock-based long‑term incentives tied to relative total shareholder return and adjusted ROE. It also details board refreshment, governance practices, risk and cybersecurity oversight, and a fully independent board chair structure.